← Back to companies
Synchron
brain-computer-interfaceneurosciencemedical-devicesInformation TechnologyManufacturingMedicalMedical Device
0 open
Brooklyn, NYFounded 2016176+ employees$330M raisedGrowthPrivate
Last round: series d · $200M · Nov 2025(6 rounds total)
Founded by Tom Oxley
Backed by(32 investors)
Double Point VenturesARCH Venture PartnersKhosla VenturesMax HodakNeurotechnology InvestorsSigma PartnersBezos ExpeditionsT.Rx CapitalIQTAlumni VenturesNational Reconstruction Fund CorporationMETIS innovativeK5 GlobalProtocol Labs
Synchron is developing a minimally invasive brain-computer interface called Stentrode. Implanted via the blood vessels (no open brain surgery), it enables patients with severe paralysis to control digital devices, with FDA breakthrough device designation.
Open Positions at Synchron (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Synchron?
